These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5708894)

  • 21. Prothrombin and antithrombin: their opposing functions in blood coagulation.
    Grannis GF; Kazal LA
    Thromb Diath Haemorrh; 1966 Dec; 16(3):497-506. PubMed ID: 5996671
    [No Abstract]   [Full Text] [Related]  

  • 22. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin agents as anticoagulants and antithrombotics: implications in drug development.
    Fareed J; Callas D; Hoppensteadt DA; Lewis BE; Bick RL; Walenga JM
    Semin Hematol; 1999 Jan; 36(1 Suppl 1):42-56. PubMed ID: 9930564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Haemostaseological aspects of perioperative blood management].
    Scherer RU
    Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiation between deficient factor V and excessive antithrombin].
    KOLLER F; WANNER J
    Helv Physiol Pharmacol Acta; 1950; 8(2):C22-5. PubMed ID: 15435979
    [No Abstract]   [Full Text] [Related]  

  • 27. [Technique of coagulation diagnostics in the clinical laboratory. IV].
    Simon KH
    Med Monatsschr; 1970 Jun; 24(6):273. PubMed ID: 5525116
    [No Abstract]   [Full Text] [Related]  

  • 28. ["Thrombin and antithrombin activity" in patients with acute myocardial infarct and in subjects treated by anticoagulant therapy].
    Jean G; Praga C; Lambertenghi G; Cortellaro M
    Folia Cardiol; 1965; 24(5):282-90. PubMed ID: 5898888
    [No Abstract]   [Full Text] [Related]  

  • 29. [Various aspects of blood coagulation in chronic pancreatitis with special reference to the antithrombin test].
    Facchini G; Fontana G; Cremonini GP; Scarcella D
    G Clin Med; 1969 Jan; 50(1):75-89. PubMed ID: 5386457
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin activity of serum from the native or recalcified blood.
    Gaertner HA; Okulski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):454-8. PubMed ID: 4168281
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postscarlatinal fulminant purpura with deficient V factor and excessive antithrombin].
    KOLLER F; GASSER C; KRUSI G; DE MURALT G
    Acta Haematol; 1950 Jul; 4(1):33-55. PubMed ID: 15432088
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of antithrombin administration in the acute phase of burn injury.
    Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
    Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins.
    de Morais KB; Vieira CO; Hirata IY; Tanaka-Azevedo AM
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Feb; 152(2):171-6. PubMed ID: 19049827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of new methods for studies in the area of blood coagulation. 3. Gel diffusion test for quantitative determination of total antithrombin capacity of plasma].
    Doleschel W
    Wien Med Wochenschr; 1972 Oct; 122(42):601-6. PubMed ID: 4628200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.